Charts Week Month
Heat map Market Overview
Sentiment Sectors ETFs
Earnings News Earnings Movers The Drift Pivots
The Big Picture Breakouts Full Earnings News
Investor Services

Earnings are the driver of stock prices and the right earnings information can help longer-term investors significantly outperform the overall stock market.

The Whisper Report ® A look at upcoming earnings from both a top-down and bottom-up basis. Grades Stocks with A+ Earnings Whisper Grades Have Significantly Outperformed the Stock Market. Call Summaries Conference call summaries. AI Call Analysis AI Conference call analysis. Earnings Daily earnings results. Guidance Daily earnings guidance from companies. Reactions Earnings Screener Short Interest Report When the short trade becomes crowded.
Trader Service

Short-term earnings trading tools built around expectations, sentiment, quantitative studies, volatility, and post-earnings drift.

Trading Strategy The current strategy based on a broad market analysis and data. Earnings Whisper Plays Combining research, sentiment, quantitative studies, and technical analysis for short-term trades. Scores Identifying the likely Earnings Announcement Premium. Power Ratings Earnings with enough power for a short-term Post-Earnings Announcement Drift. Whisperings ^TM Whisperings are comments from analysts about upcoming earnings releases. AI Call Rankings Find which companies had the strongest or weakest conference calls. Option Trades Volatility Options Activity Unusual options activity around earnings. Setups Unusual options activity around earnings. Reversals Unusual options activity around earnings. Spikes Unusual options activity around earnings.
Dashboard

PCRX Pacira BioSciences, Inc.

NASDAQ

$23.00

Pacira BioSciences, Inc. (PCRX) Earnings News

Earnings press releases and Earnings Whispers previews for Pacira BioSciences, Inc. (PCRX), newest first.

Tuesday August 4, 2026 4:01 PM ET

Pacira BioSciences Reports Second Quarter 2026 Financial Results

Wednesday July 22, 2026 8:00 AM ET

Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026

Thursday May 28, 2026 9:18 AM ET

DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTION

Wednesday May 27, 2026 4:20 PM ET

Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees

Thursday May 21, 2026 1:53 PM ET

A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLC

Wednesday May 20, 2026 12:28 PM ET

DOMA Perpetual Director Nominees Send Letter to Shareholders of Pacira Biosciences

Wednesday May 13, 2026 10:58 AM ET

DOMA Perpetual Issues & Mails Letter to Shareholders of Pacira BioSciences - Along with its Definitive Proxy Statement & WHITE Proxy Card - Urging Shareholders to Vote "FOR" DOMA's Three Highly Qualified, Independent Board Candidates

Tuesday May 5, 2026 4:20 PM ET

Pacira BioSciences Mails Letter to Stockholders

Thursday April 30, 2026 4:01 PM ET

Pacira BioSciences Reports First Quarter 2026 Financial Results

Tuesday April 28, 2026 4:20 PM ET

Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders

Thursday April 16, 2026 8:00 AM ET

Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026

Thursday February 26, 2026 4:01 PM ET

Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results